Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt J Farrer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Genetics|February 27, 2019
Doubts about TMEM230 as a gene for parkinsonismMatt J Farrer
The New England Journal of Medicine|July 3, 2014
Mutant COQ2 in multiple-system atrophyBeom S Jeon, Matt J Farrer, Stephanie F Bortnick, et al.
Trends in Molecular Medicine|January 13, 2006
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?Julie P Taylor, Ignacio F Mata, Matt J Farrer
Parkinsonism & Related Disorders|December 2, 2017
Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's diseaseCynthia D J Kusters, Kimberly C Paul, Ilaria Guella, et al.
Human Molecular Genetics|October 11, 2002
Functional association of the parkin gene promoter with idiopathic Parkinson's diseaseAndrew B West, Demetrius Maraganore, Julia Crook, et al.
Annals of Neurology|September 30, 2004
alpha-Synuclein promoter confers susceptibility to Parkinson's diseasePhilippe Pals, Sarah Lincoln, Jonathan Manning, et al.
Human Molecular Genetics|May 23, 2003
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's diseaseFrank P Marx, Carsten Holzmann, Karsten M Strauss, et al.
NPJ Parkinson'S Disease|May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onsetKatalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
NPJ Parkinson'S Disease|April 20, 2026
Genome-wide association study of copy number variations in Parkinson's diseaseZied Landoulsi, Ashwin Ashok Kumar Sreelatha, Nicole Kuznetsov, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2022
The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease RevisitedCloé Domenighetti, Venceslas Douillard, Pierre-Emmanuel Sugier, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Genetics|February 27, 2019
Doubts about TMEM230 as a gene for parkinsonismMatt J Farrer
The New England Journal of Medicine|July 3, 2014
Mutant COQ2 in multiple-system atrophyBeom S Jeon, Matt J Farrer, Stephanie F Bortnick, et al.
Trends in Molecular Medicine|January 13, 2006
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?Julie P Taylor, Ignacio F Mata, Matt J Farrer
Parkinsonism & Related Disorders|December 2, 2017
Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's diseaseCynthia D J Kusters, Kimberly C Paul, Ilaria Guella, et al.
Human Molecular Genetics|October 11, 2002
Functional association of the parkin gene promoter with idiopathic Parkinson's diseaseAndrew B West, Demetrius Maraganore, Julia Crook, et al.
Annals of Neurology|September 30, 2004
alpha-Synuclein promoter confers susceptibility to Parkinson's diseasePhilippe Pals, Sarah Lincoln, Jonathan Manning, et al.
Human Molecular Genetics|May 23, 2003
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's diseaseFrank P Marx, Carsten Holzmann, Karsten M Strauss, et al.
NPJ Parkinson'S Disease|May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onsetKatalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
NPJ Parkinson'S Disease|April 20, 2026
Genome-wide association study of copy number variations in Parkinson's diseaseZied Landoulsi, Ashwin Ashok Kumar Sreelatha, Nicole Kuznetsov, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2022
The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease RevisitedCloé Domenighetti, Venceslas Douillard, Pierre-Emmanuel Sugier, et al.
Pageof 2